• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

​​​​​​​Highly Pathogenic Avian Influenza A(H5N1) Virus Infection in a Dairy Farm Worker (CORRESPONDENCE, NEJM, May 3, 2024)

Pathfinder

Editor, Senior Moderator
CORRESPONDENCE

Highly Pathogenic Avian Influenza A(H5N1) Virus Infection in a Dairy Farm Worker

Published May 3, 2024
DOI: 10.1056/NEJMc2405371

snip

Viral sequences from cattle and from the worker maintained primarily avian genetic characteristics and lacked changes in the hemagglutinin gene that would affect receptor-binding specificity (e.g., binding to α2-6–linked sialic acid receptors, primarily located in the human upper respiratory tract) and transmission risk to humans. The virus identified in the worker’s specimen had a change (PB2 E627K) that has been associated with viral adaptation to mammalian hosts and detected previously in humans and other mammals infected with HPAI A(H5N1) viruses and other avian influenza A virus subtypes, including A(H7N9) and A(H9N2). No genetic markers associated with reduced susceptibility to influenza antiviral drugs approved by the Food and Drug Administration were identified. Additional results and interpretation and discussion of findings, unanswered questions, recommendations, and references are provided in the Supplementary Appendix. The hemagglutinin of the virus was found to be closely related to two existing clade 2.3.4.4b A(H5N1) candidate vaccine viruses. Because influenza A(H5N1) viruses have pandemic potential, these candidate vaccine viruses are available to manufacturers and could be used to produce vaccine if needed.

Timothy M. Uyeki, M.D., M.P.H.
Centers for Disease Control and Prevention, Atlanta, GAtmu0@cdc.gov
Scott Milton, M.D.
Cherissa Abdul Hamid, D.V.M., M.P.H.
Texas Department of State Health Services, Lubbock, TX
Cynthia Reinoso Webb, Ph.D.
Steven M. Presley, Ph.D.
Texas Tech University Bioterrorism Response Laboratory, Lubbock, TX
Varun Shetty, M.D.
Susan N. Rollo, D.V.M., Ph.D.
Diana L. Martinez, Ph.D., M.P.H.
Saroj Rai, Ph.D., M.P.H.
Emilio R. Gonzales, M.P.H.
Texas Department of State Health Services, Austin, TX
Krista L. Kniss, M.P.H.
Yunho Jang, Ph.D.
Julia C. Frederick, Ph.D.
Juan A. De La Cruz, M.S.
Jimma Liddell, M.S.
Han Di, Ph.D.
Marie K. Kirby, Ph.D.
John R. Barnes, Ph.D.
C. Todd Davis, Ph.D.
Centers for Disease Control and Prevention, Atlanta, GA​

...

https://www.nejm.org/doi/full/10.1056/NEJMc2405371
 
Last edited by a moderator:
Back
Top